3Hu K, Yang J, Tanaka S, et al. Tissue-type plasminogen activars acts as a cytokine that triggers intracellu[ar signal transduction and induces matrix metalloproteinase-9 gene expression[J]. J Biol Chem, 2006,281 ( 4 ) : 2120-2127.
4I)iaz VM, H urtado M, Thomson TM, et al. Specific inter- action of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells ac- tivates plasminogen and promotes invasion in vitro[J]. Gut,2004,53(7) :993-1000.
5Poon R'F, Ng IO, Lau C,et al. Tumor Microvessel Density as a Predictor of Recurrence After Resection of Hepato cellular Carcinoma: A Prospective Study[J]. J Clin Oncol, 2002,20 (7) : 1775-1785.
6Cassln B,Bossmar T, Lecander I. Plasminogen activators and plasminogen activator inhibitors in blood and tumor fluids of patients with ovarian cancer[J]. Eur J Cancer, 1994,30A(9) : 1302-1309.
7l)e (Tremoux P, Grandin L, Di6ras V, et al. Urokinasytype Plasminogen Activator and Plasminogen-activator-inhibitor Type 1 Predict Metastases in Good Prognosis Breast Cancer Patients[J]. Anticancer Res, 2009,29 (5) : 1475-1482.
